SCHEMBL4117359

SCHEMBL4117359

CO/C(C)=C/c1cc(C=O)n(-c2ccc(Cl)cc2C(=O)c2cccc(OC)c2OC)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 3/20 0.38
NPSR1 Q6W5P4 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
LMNA P02545 1/20 0.38
FNTA P49354 1/20 0.37
FNTB P49356 1/20 0.37
POLB P06746 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35
TUBB4A P04350 3/20 0.34
TUBB P07437 3/20 0.34
TUBA3C P0DPH7 3/20 0.34
TUBA1B P68363 3/20 0.34
TUBA4A P68366 3/20 0.34
TUBB4B P68371 3/20 0.34
TUBB3 Q13509 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4117362 1.00 ALDH1A1 (0.38) ALDH1A1KDM4ENPSR1NPC1RAB9A
SCHEMBL13775477 0.93 FNTA (0.38) ALDH1A1KDM4ENPSR1NPC1RAB9A
SCHEMBL4112003 0.84 ALDH1A1 (0.39) ALDH1A1KDM4ENPSR1NPC1RAB9A
SCHEMBL4112006 0.84 ALDH1A1 (0.39) ALDH1A1KDM4ENPSR1NPC1RAB9A
SCHEMBL4121567 0.84 KDM4E (0.35) ALDH1A1KDM4ENPSR1NPC1RAB9A
SCHEMBL4121572 0.84 KDM4E (0.35) ALDH1A1KDM4ENPSR1NPC1RAB9A
SCHEMBL4123934 0.82 GAA (0.51) ALDH1A1KDM4ENPSR1NPC1RAB9A
SCHEMBL4110749 0.79 GAA (0.39)
SCHEMBL13775474 0.79 FNTA (0.38) ALDH1A1KDM4ENPSR1NPC1RAB9A
SCHEMBL4111889 0.76 TUBB4A (0.43) ALDH1A1KDM4ENPSR1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
EP-1939205-A1 TRICYCLIC COMPOUND Daiichi Sankyo Company, Limited (JP) 2008-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181942-A1 TRICYCLIC COMPOUNDS FDFT1, COASY, HMGCR ALDH1A1 1587/4885KDM4E 2123/4885NPSR1 972/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.